• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Consumer Cyclical·2812.T
Share

Yaizu Suisankagaku Industry Co.,Ltd. Stocks

¥ 0Last Updated 23.03.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

¥ 102.97M

¥ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Yaizu Suisankagaku Industry Co.,Ltd. manufactures and sells natural seasonings, healthy foods, functional foods, and other foods in Japan. The company offers seasonings and processed dried foods, including instant bouillons, various types of soup stocks for noodles, instant noodles, frozen foods, faux crabs, sweets, snack foods, seasoning mixes for rice, and rice with green tea mixes. It also provides various types of supplements and functional beverages, cosmetics, and diagnostic drugs. In addition, the company offers functional materials, such as n-acetylglucosamine, anserine, theaflavin, chitin oligosaccharide, chitosan, chitosan oligosaccharide, glucosamine, chondroitin sulfate, and fucoidan. Yaizu Suisankagaku Industry Co.,Ltd. was founded in 1959 and is headquartered in Shizuoka, Japan.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably priced on P

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

03.08.2026 11:43

SpaceX's Earnings Report, the Job Market, and Big Pharma: What Investors Can Expect This Week

03.08.2026 11:25

Alibaba has unveiled an AI model comparable to Anthropic's cutting-edge developments

03.08.2026 10:12

Top Stories This Morning: U.S.-Iran Talks, a Major Pharmaceutical Deal, and a Market Correction in Asia

03.08.2026 10:09

Oil prices plummeted by more than 7%. Trump announced a new round of talks with Iran

02.08.2026 21:00

CXMT's 466% Debut, Shein's Losses, and Trump's Son's Investments: The Top IPO Stories as of August 2

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026